U.S. Life Sciences Stock News

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...

NeoVolta (NEOV) has just posted its Q2 2026 numbers, with Q1 2026 revenue at US$6.7 million and a net loss of US$1.2 million, translating into basic EPS of a US$0.04 loss. The company has seen quarterly revenue move from US$0.6 million in Q1 2025 through US$1.1 million in Q2 2025, US$2.0 million in Q3 2025 and US$4.8 million in Q4 2025 to US$6.7 million in Q1 2026, while EPS over the same stretch ranged from a loss of US$0.03 to a loss of US$0.05 per share. For investors, the latest set of...

If you are wondering whether TPG’s share price reflects its underlying worth right now, you are not alone. This article is here to frame the key valuation questions you might be asking. After reaching a recent close of US$49.53, the stock has seen a 10% decline over the last 7 days and a 26.2% decline over the last 30 days, while still showing a 64.5% return over 3 years and mixed results over shorter periods including year to date and the last 12 months. Recent news coverage around TPG has...

On February 4, 2026, Oncolytics Biotech announced that the FDA granted Fast Track Designation to pelareorep combined with bevacizumab and FOLFIRI for second-line treatment of KRAS-mutant, microsatellite-stable metastatic colorectal cancer. The designation is backed by clinical data showing pelareorep-based therapy delivered higher response rates and longer survival measures than existing standard-of-care options in this hard-to-treat subgroup. With the FDA’s Fast Track Designation in place,...

Warrior Met Coal (NYSE:HCC) has started longwall production at its Blue Creek mine around eight months ahead of its original schedule. The company reports that this early start is supporting record production, sales, and earnings in 2025 in what it describes as a challenging market. Warrior Met Coal has also finalized two federal coal leases that add major coal reserves to its asset base. Management highlights these milestones as key drivers for planned production and sales expansion in 2026...

DraftKings (DKNG) closed out FY 2025 with Q4 revenue of US$1.99b and basic EPS of US$0.28, while trailing twelve month EPS edged into positive territory at US$0.01 on revenue of US$6.05b. This helped set the tone for a results season where profitability is firmly in focus. The company has seen quarterly revenue move from US$1.39b in Q4 2024 to US$1.99b in Q4 2025, with basic EPS shifting from a loss of US$0.28 per share to earnings of US$0.28 per share over the same period. This puts the...

Corsair Gaming, Inc. reported its fourth-quarter and full-year 2025 results on 12 February 2026, with Q4 sales of US$436.86 million and net income of US$25.79 million, alongside its first-ever US$50 million share repurchase authorization. While full-year 2025 still showed a net loss of US$16.16 million, the sharp improvement from the prior year and initiation of buybacks highlight a focus on profitability and capital returns. Next, we'll examine how Corsair's strong Q4 profitability and...

Credit Acceptance (CACC) just closed out FY 2025 with fourth quarter revenue of US$336.5 million and basic EPS of US$11.18, backed by trailing twelve month revenue of about US$1.2 billion and EPS of US$37.02. The company has seen quarterly revenue move from US$254.4 million in Q3 FY 2024 to US$336.5 million in Q4 FY 2025, while basic EPS stepped from US$6.42 to US$11.18 over the same stretch, framing a story in which improving profitability and a 34.2% trailing net margin shape how investors...

Viasat (NasdaqGS:VSAT) has partnered with Astralintu to supply advanced antennas for a new Equatorial Ground Station. The station is intended to extend Viasat’s Real-Time Earth ground network coverage across the Southern Caribbean, South America, and the Eastern Pacific. This move targets gaps in satellite connectivity and real-time data access for commercial and government users in underserved regions. For you as an investor, this partnership sits at the core of Viasat’s ground segment...

Boot Barn Holdings (NYSE:BOOT) has outlined an aggressive new store expansion plan. The company is targeting a long term goal of 1,200 locations across the United States. Management has highlighted strong unit economics for new stores and is aiming for sustained double digit annual unit growth. Boot Barn Holdings, which focuses on western and work related apparel, footwear, and accessories, is moving into a larger phase of its store rollout. For you as an investor, the shift from regional...

Bogota Financial (BSBK) has just posted another profitable quarter, with Q3 FY 2025 revenue of US$4.3 million and basic EPS of US$0.04 supported by net income of US$0.5 million and a net interest margin of 1.8% as investors keep an eye on how sustainable this run rate looks. Over recent periods, the company has seen revenue move from US$3.0 million in Q2 FY 2024 to US$4.6 million in Q1 FY 2025 and US$4.0 million in Q2 FY 2025, while basic EPS shifted from a loss of US$0.03 in Q2 FY 2024 to a...

Westwood Holdings Group (WHG) has wrapped up FY 2025 with fourth quarter revenue of US$27.1 million and basic EPS of US$0.22, rounding out a trailing 12 month picture that includes total revenue of US$97.8 million and EPS of US$0.84. Over recent periods the company has seen revenue move from US$25.6 million and EPS of US$0.25 in Q4 2024 to Q3 2025 levels of US$24.3 million and EPS of US$0.44 before the latest quarter, while trailing net profit margin has shifted from 2.3% to 7.2%. This gives...

Trupanion (TRUP) just wrapped FY 2025 with Q4 revenue of US$376.9 million and basic EPS of US$0.13, while trailing twelve month EPS sat at US$0.45 on revenue of about US$1.4 billion. The company has seen revenue move from US$337.3 million in Q4 2024 to US$376.9 million in Q4 2025, with quarterly basic EPS shifting from US$0.04 a year ago to US$0.13 most recently. This puts the focus squarely on how sustainably margins are settling at these levels. See our full analysis for Trupanion. With the...

PAMT just posted its FY 2025 numbers with Q4 revenue of US$141.3 million and a basic EPS loss of US$1.40, while net income excluding extra items came in at a loss of US$29.3 million. The company has seen quarterly revenue move from US$166.5 million and a basic EPS loss of US$1.45 in FY 2024 Q4 to US$141.3 million and a US$1.40 loss per share in FY 2025 Q4. Trailing twelve month revenue was US$598.1 million with a cumulative EPS loss of US$2.48. For investors, the key point this quarter is how...

If you are wondering whether Sphere Entertainment's share price matches its underlying worth, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$115.70, with returns of 24.1% over 7 days, 17.8% over 30 days, 22.7% year to date and 140.0% over 1 year. These figures naturally raise questions about how much future upside or downside is already reflected in the price. Recent coverage has focused on Sphere Entertainment's high profile...

In February 2026, Avient Corporation reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$760.6 million while full-year net income decreased to US$81.9 million despite slightly higher annual sales of US$3.26 billion. Alongside weaker GAAP earnings, Avient delivered 80 basis points of adjusted EBITDA margin expansion, double-digit adjusted EPS growth in Q4, and US$150 million of debt reduction, highlighting the impact of cost controls and higher-value mix in...

In early February 2026, Edgewell Personal Care reported first-quarter 2026 results showing sales of US$422.8 million, up from US$415.1 million a year earlier, alongside a net loss of US$65.7 million and continued zero share repurchases under its most recent buyback authorization. Despite the wider loss and lack of recent buyback activity, the company affirmed a quarterly dividend of US$0.15 per share, highlighting management’s willingness to continue returning cash to shareholders while...

Dana Incorporated appointed Byron Foster as CEO, effective July 1, 2026, with Bruce McDonald remaining Chairman of the Board. The company announced a 20% increase in its quarterly dividend. Dana expanded its equity buyback authorization to $2b and extended the plan through 2030. For investors tracking NYSE:DAN, these corporate moves come as the share price stands at $33.39, with the stock up 5.4% over the past week and 23.4% over the past month. Longer term, Dana has posted gains of 33.8%...

In the past week, XPLR Infrastructure, LP reported fourth-quarter 2025 results showing sales of US$249 million, net income of US$29 million, and earnings of US$0.30 per unit, compared with higher sales and a loss a year earlier. Despite a full-year loss of US$28 million on largely steady annual sales, the partnership highlighted strong cash generation, US$1.88 billion of adjusted EBITDA, and an amended revolving credit facility that reduces committed size while extending maturity to...

Credicorp FY 2025 earnings snapshot Credicorp (NYSE:BAP) has just posted another set of hefty numbers for FY 2025, with Q3 2025 revenue at S/5.3b and basic EPS of S/21.89, while trailing twelve month EPS sits at S/81.43. The group has seen revenue move from S/18.2b and EPS of S/69.24 on a trailing basis in Q4 2024 to S/20.4b and S/81.43 by Q3 2025, which puts the focus on how efficiently those earnings are being generated through its margins. See our full analysis for Credicorp. With the...

Avery Dennison reported fourth quarter results that highlighted resilience in margins and growth in high value categories. The Intelligent Labels segment showed solid momentum, supported by broader use cases and new customer adoption. Management pointed to continued opportunities in Intelligent Labels and reaffirmed its focus on higher value product lines. For investors watching NYSE:AVY, the latest quarter puts more attention on how the business mix is evolving rather than just the top...

Nebius Group (NBIS) just wrapped up FY 2025 with Q4 total revenue of US$227.7 million and a basic EPS loss of US$0.99, alongside net income from continuing operations showing a loss of US$249.6 million. The company has seen quarterly revenue move from US$37.9 million in Q4 2024 to US$55.3 million in Q1 2025, US$105.1 million in Q2 and US$146.1 million in Q3, while EPS swung between a loss of US$0.57 in Q4 2024 and a gain of US$1.05 in Q2 2025 before returning to a loss in the latest quarter...

Alnylam Pharmaceuticals (ALNY) books FY 2025 profit as quarterly revenue tops US$1 billion Alnylam Pharmaceuticals (ALNY) has capped FY 2025 with fourth quarter revenue of US$1,097.0 million and basic EPS of US$1.41, alongside net income of US$186.4 million that continues the company’s recent move into profitability. The company has seen revenue step up from US$593.2 million and basic EPS of US$0.65 loss in Q4 2024 to US$594.2 million with EPS of US$0.44 loss in Q1 2025, US$773.7 million with...